Mar Cor Purification and Rephile Biosciences sign distribution agreement for North American markets

20-Jan-2017 - USA

Cantel Medical Subsidiary, Mar Cor Purification signed a distribution agreement with RephiLe Biosciences for distributing their laboratory water systems to customers in North America. These systems are used in research facilities, universities, hospitals and other critical high purity, low volume applications. The broad line of systems are capable of producing various grades of high purity water used in lab, research, blood analyzers and other grades of water.

“The RephiLe line of laboratory systems are designed to meet the increasing requirements of our customers by providing technically advanced systems coupled with a robust design at a very attractive price point”, states Christopher Fournier, VP Marketing, Mar Cor. Our direct sales force of over 50 professional sales people will have full access to the entire product line in order to address the specialized capacity requirements of the laboratory market.

“Mar Cor provides unparalleled support to its water purification customers from a sales and service perspective. With Mar Cor’s 30 service and regeneration centers across North America, coupled with experienced Sales and Service Teams, our customers will have coverage for installation, service, and maintenance of RephiLe Biosciences water purification systems.” States Peter Lucas, RephiLe Biosciences President of North America. “This agreement continues to build upon our strategic and tactical expansion in North America to offer our customers outstanding products and support.”

https://www.chemeurope.com/en/news/161452/mar-cor-purification-and-rephile-biosciences-sign-distribution-agreement-for-north-american-markets.html